查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1575498

酵素法 DNA 合成市場：按技術、成分和應用分類 - 2025-2030 年全球預測

Enzymatic DNA Synthesis Market by Technology (Liquid-Phase Synthesis, Microchip-Based Synthesis, PCR Based Enzymatic Synthesis), Component (Reagents), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

酵素法 DNA 合成市場 2023 年估值為 48.7 億美元，預計到 2024 年將達到 53.7 億美元，複合年成長率為 10.51%，預計到 2030 年將達到 98.2 億美元。

酶促 DNA 合成是一種創新的生物技術，可利用酶催化反應促進 DNA 序列的生產，比傳統化學合成方法提供更高的精度和效率。對酵素法 DNA 合成的需求源於個人化醫療、合成生物學和基因療法中的應用，並且受到對快速、高保真 DNA 構建日益成長的需求的推動。其應用範圍擴展到實驗室、製藥公司和農業生物技術公司，這些領域的高通量和特異性非常重要。最終用途範圍涵蓋學術和工業部門，專門從事基因工程、診斷和藥物開發。市場成長受到不斷擴大的基因組學市場、生物技術研究投資的增加以及對永續和可擴展的 DNA 合成方法的需求的影響。酶工程和自動化的進步正在提高合成能力，並為公司提供差異化解決方案創造機會。向環境友善生物技術製程的轉變凸顯了綠色合成技術的潛在機會。挑戰包括與酵素工程相關的技術挑戰、大規模生產的成本效益問題以及醫療保健應用中的監管障礙。此外，克服智慧財產權問題和標準化合成通訊協定是市場成長的條件。創新的關鍵領域包括開發具有更高特異性和活性的新型酵素、整合用於序列最佳化的人工智慧增強設計工具以及改進合成製程的微流體技術進步。市場競爭激烈，但發展迅速，許多新興企業和現有企業都以爭奪市場佔有率為目標，需要不斷創新。對於希望利用這一成長的公司的研究提案包括投資研究合作、專注於具有成本效益和可擴展的生產方法，以及加強與學術機構的夥伴關係，以保持技術進步的前沿。使您的業務策略適應個人化醫療和永續生物技術解決方案的趨勢對於永續成長和市場領導至關重要。

主要市場統計
基準年[2023] 48.7億美元
預測年份 [2024] 53.7億美元
預測年份 [2030] 98.2億美元
複合年成長率（%） 10.51%

市場動態：快速發展的酵素 DNA 合成市場的關鍵市場洞察

供需的動態交互作用正在改變酵素 DNA 合成市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 在診斷和個人化醫療中使用合成 DNA 來改善患者預後
    • 基因組資料的擴展以及研究和臨床環境中快速 DNA 合成的需求
    • 主要企業之間的策略聯盟加速創新DNA合成解決方案的開發
    • 與傳統方法相比，酶促 DNA 合成的成本效益和擴充性
  • 市場限制因素
    • 確保 DNA 酶合成的精確性和準確性的複雜性和技術挑戰可能會導致潛在的錯誤和低效率
    • 酶促 DNA 合成技術的研發高成本，限制了其可近性和可負擔性。
  • 市場機會
    • 製藥公司擴大採用酵素法 DNA 合成進行藥物開發和篩檢
    • 一種創新的酶促 DNA 合成解決方案，可在合成生物學中快速原型製作DNA 構建體的原型
    • 高通量酶促DNA合成技術支援自訂DNA序列的大規模生產
  • 市場挑戰
    • 與 DNA 酶合成技術相關的監管障礙和合規問題
    • 由於與現有 DNA 合成技術的競爭，限制了酶法 DNA 合成的市場滲透

波特五力：駕馭酵素 DNA 合成市場的策略工具

波特的五力框架是了解酵素 DNA 合成市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解酵素法 DNA 合成市場的外部影響

外部宏觀環境因素在塑造酵素 DNA 合成市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解酵素法 DNA 合成市場的競爭狀況

酶 DNA 合成市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣酵素法DNA合成市場供應商績效評估

FPNV定位矩陣是評估酵素DNA合成市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製酶促 DNA 合成市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，酶促 DNA 合成市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 在診斷和個人化醫療中使用合成 DNA 以獲得更好的患者治療效果
      • 基因組資料的擴展以及研究和臨床環境中快速 DNA 合成的需求
      • 主要參與者之間的策略合作加速創新 DNA 合成解決方案的開發
      • 與傳統方法相比，酶促 DNA 合成的成本效益和擴充性
    • 抑制因素
      • 確保酶促 DNA 合成的精確性和準確性的複雜性和技術挑戰可能會導致潛在的錯誤和低效率
      • 酶促 DNA 合成技術的研發成本高昂，限制了其可及性和可負擔性
    • 機會
      • 製藥公司在藥物開發和篩檢中更多地採用酵素法 DNA 合成
      • 創新的酶促 DNA 合成解決方案可實現合成生物學 DNA 結構的快速原型製作
      • 高通量酶促 DNA 合成技術，支援大規模生產客自訂DNA 序列
    • 任務
      • 與 DNA 酶合成技術相關的監管障礙和合規問題
      • 來自成熟 DNA 合成技術的競爭限制了酶法 DNA 合成的市場滲透
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章酶法 DNA 合成市場：依技術分類

  • 液相合成
  • 基於微晶片的合成
  • 基於PCR的酶合成
  • 固相合成

第 7 章 酶法 DNA 合成市場：依組成部分

  • 試劑
    • 緩衝
    • 酵素
    • 核苷酸

第8章酶法 DNA 合成市場：依應用分類

  • 生物技術研究
  • 臨床診斷
  • 藥物發現
  • 治療藥物

第9章 美洲酶法DNA合成市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區酵素法DNA合成市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的酵素法 DNA 合成市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C059D

The Enzymatic DNA Synthesis Market was valued at USD 4.87 billion in 2023, expected to reach USD 5.37 billion in 2024, and is projected to grow at a CAGR of 10.51%, to USD 9.82 billion by 2030.

Enzymatic DNA synthesis is a transformative biotechnology that facilitates the production of DNA sequences using enzyme-catalyzed reactions, offering precision and efficiency over traditional chemical synthesis methods. The necessity for enzymatic DNA synthesis arises from its applications in personalized medicine, synthetic biology, and gene therapy, driven by increased demand for rapid and high-fidelity DNA construction. Applications extend to research laboratories, pharmaceutical companies, and agricultural biotechnology firms, where high throughput and specificity are critical. The end-use scope encompasses academic and industrial sectors specializing in genetic engineering, diagnostics, and drug development. Market growth is influenced by the expanding genomics market, rising investments in biotechnology research, and the need for sustainable and scalable DNA synthesis methods. Advances in enzyme engineering and automation enhance synthesis capabilities, creating opportunities for companies to offer differentiated solutions. A shift towards environmentally friendly biotech processes underscores potential opportunities in green synthesis technologies. Limitations include the technical challenges associated with enzyme engineering, concerns over the cost-effectiveness for large-scale production, and regulatory hurdles in healthcare applications. Furthermore, market growth is contingent on overcoming intellectual property issues and standardizing synthesis protocols. Critical areas of innovation include developing novel enzymes with improved specificity and activity, integrating AI-enhanced design tools for sequence optimization, and advancing microfluidic technologies for improved synthesis processes. The nature of the market is competitive but rapidly evolving, with numerous startups and established companies striving for market share, necessitating continual innovation. Recommendations for businesses seeking to leverage this growth include investing in research collaborations, focusing on cost-effective scalable production methods, and enhancing partnerships with academic institutions to stay at the forefront of technological advancements. Adapting business strategies to align with the trends in personalized medicine and sustainable biotechnology solutions will be crucial for sustained growth and market leadership.

KEY MARKET STATISTICS
Base Year [2023] USD 4.87 billion
Estimated Year [2024] USD 5.37 billion
Forecast Year [2030] USD 9.82 billion
CAGR (%) 10.51%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Enzymatic DNA Synthesis Market

The Enzymatic DNA Synthesis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Adoption of synthetic DNA in diagnostics and personalized medicine for better patient outcomes
    • Expansion of genomic data and need for rapid DNA synthesis in research and clinical settings
    • Strategic collaborations between key players to accelerate the development of innovative DNA synthesis solutions
    • Cost-effectiveness and scalability of enzymatic DNA synthesis compared to traditional methods
  • Market Restraints
    • Complexity and technical challenges in ensuring the precision and accuracy of enzymatic DNA synthesis leading to potential errors and inefficiencies
    • High costs associated with research and development in enzymatic DNA synthesis technology limiting accessibility and affordability
  • Market Opportunities
    • Increasing adoption of enzymatic DNA synthesis by pharmaceutical companies for drug development and screening
    • Innovative enzymatic DNA synthesis solutions enabling rapid prototyping of DNA constructs for synthetic biology
    • High-throughput enzymatic DNA synthesis technologies supporting large-scale production of custom DNA sequences
  • Market Challenges
    • Regulatory hurdles and compliance issues associated with enzymatic DNA synthesis technologies
    • Competition from established DNA synthesis technologies limits market penetration of enzymatic DNA synthesis

Porter's Five Forces: A Strategic Tool for Navigating the Enzymatic DNA Synthesis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Enzymatic DNA Synthesis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Enzymatic DNA Synthesis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Enzymatic DNA Synthesis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Enzymatic DNA Synthesis Market

A detailed market share analysis in the Enzymatic DNA Synthesis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Enzymatic DNA Synthesis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Enzymatic DNA Synthesis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Enzymatic DNA Synthesis Market

A strategic analysis of the Enzymatic DNA Synthesis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enzymatic DNA Synthesis Market, highlighting leading vendors and their innovative profiles. These include Ansa Biotechnologies, BioCat, Bioneer, Camena Bioscience, Codex DNA, DNA Script, Eurofins Genomics, Evonetix, Genewiz, GenScript, Integrated DNA Technologies, Kuano, Molecular Assemblies, Neuex, Nuclera, OriGene Technologies, Sigma-Aldrich, Telesis Bio, Thermo Fisher Scientific, and Twist Bioscience.

Market Segmentation & Coverage

This research report categorizes the Enzymatic DNA Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Liquid-Phase Synthesis, Microchip-Based Synthesis, PCR Based Enzymatic Synthesis, and Solid-Phase Synthesis.
  • Based on Component, market is studied across Reagents. The Reagents is further studied across Buffers, Enzymes, and Nucleotides.
  • Based on Application, market is studied across Biotechnology Research, Clinical Diagnostics, Drug Discovery, and Therapeutics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Adoption of synthetic DNA in diagnostics and personalized medicine for better patient outcomes
      • 5.1.1.2. Expansion of genomic data and need for rapid DNA synthesis in research and clinical settings
      • 5.1.1.3. Strategic collaborations between key players to accelerate the development of innovative DNA synthesis solutions
      • 5.1.1.4. Cost-effectiveness and scalability of enzymatic DNA synthesis compared to traditional methods
    • 5.1.2. Restraints
      • 5.1.2.1. Complexity and technical challenges in ensuring the precision and accuracy of enzymatic DNA synthesis leading to potential errors and inefficiencies
      • 5.1.2.2. High costs associated with research and development in enzymatic DNA synthesis technology limiting accessibility and affordability
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing adoption of enzymatic DNA synthesis by pharmaceutical companies for drug development and screening
      • 5.1.3.2. Innovative enzymatic DNA synthesis solutions enabling rapid prototyping of DNA constructs for synthetic biology
      • 5.1.3.3. High-throughput enzymatic DNA synthesis technologies supporting large-scale production of custom DNA sequences
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles and compliance issues associated with enzymatic DNA synthesis technologies
      • 5.1.4.2. Competition from established DNA synthesis technologies limits market penetration of enzymatic DNA synthesis
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Enzymatic DNA Synthesis Market, by Technology

  • 6.1. Introduction
  • 6.2. Liquid-Phase Synthesis
  • 6.3. Microchip-Based Synthesis
  • 6.4. PCR Based Enzymatic Synthesis
  • 6.5. Solid-Phase Synthesis

7. Enzymatic DNA Synthesis Market, by Component

  • 7.1. Introduction
  • 7.2. Reagents
    • 7.2.1. Buffers
    • 7.2.2. Enzymes
    • 7.2.3. Nucleotides

8. Enzymatic DNA Synthesis Market, by Application

  • 8.1. Introduction
  • 8.2. Biotechnology Research
  • 8.3. Clinical Diagnostics
  • 8.4. Drug Discovery
  • 8.5. Therapeutics

9. Americas Enzymatic DNA Synthesis Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Enzymatic DNA Synthesis Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Enzymatic DNA Synthesis Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ansa Biotechnologies
  • 2. BioCat
  • 3. Bioneer
  • 4. Camena Bioscience
  • 5. Codex DNA
  • 6. DNA Script
  • 7. Eurofins Genomics
  • 8. Evonetix
  • 9. Genewiz
  • 10. GenScript
  • 11. Integrated DNA Technologies
  • 12. Kuano
  • 13. Molecular Assemblies
  • 14. Neuex
  • 15. Nuclera
  • 16. OriGene Technologies
  • 17. Sigma-Aldrich
  • 18. Telesis Bio
  • 19. Thermo Fisher Scientific
  • 20. Twist Bioscience

LIST OF FIGURES

  • FIGURE 1. ENZYMATIC DNA SYNTHESIS MARKET RESEARCH PROCESS
  • FIGURE 2. ENZYMATIC DNA SYNTHESIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ENZYMATIC DNA SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ENZYMATIC DNA SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENZYMATIC DNA SYNTHESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ENZYMATIC DNA SYNTHESIS MARKET DYNAMICS
  • TABLE 7. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY LIQUID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MICROCHIP-BASED SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PCR BASED ENZYMATIC SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY NUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. ENZYMATIC DNA SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. ENZYMATIC DNA SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023